“When I Stop My Medication, Everything Goes Wrong”: Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication

Niemeyer, Larissa; Schumm, Lucca; Mechler, Konstantin; Jennen-Steinmetz, Christine; Dittmann, Ralf W.; Häge, Alexander

doi:10.1089/cap.2018.0072

Cited by 11 publications

(10 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, we recommend that clinicians do not consider parents' assessments as a suffi ciently reliable source of information in this regard. recent fi ndings suggest that such subjective factors appear to be more important for real-life adherence in adolescents than objective benefi ts and the side eff ects of medication (Charach et al, 2014;Niemeyer et al, 2018). In a fi rst analysis of data collected within the SEMA project, we found diff erent parameters of adolescents' subjective experiences, perceptions, and attitudes that characterized the group of adolescents with reduced adherence to psychotropic medication (for details, see Niemeyer et al, 2018).…”

Section: Discussionmentioning

confidence: 93%

“…recent fi ndings suggest that such subjective factors appear to be more important for real-life adherence in adolescents than objective benefi ts and the side eff ects of medication (Charach et al, 2014;Niemeyer et al, 2018). In a fi rst analysis of data collected within the SEMA project, we found diff erent parameters of adolescents' subjective experiences, perceptions, and attitudes that characterized the group of adolescents with reduced adherence to psychotropic medication (for details, see Niemeyer et al, 2018). In addition, the results from this second analysis suggest that clinicians should not rely exclusively on parents' assessments to identify adolescent patients' attitudes toward psychotropic medication.…”

Section: Discussionmentioning

confidence: 99%

“…Following the same approach as in Niemeyer et al (2018), the classifi cation of patients' medication adherence was based on the MARS and the patient version of the QATT. Patients who fulfi lled at least one of the following criteria were classifi ed as not completely adherent:…”

Section: Defi Nitionmentioning

confidence: 99%

See 2 more Smart Citations

Medication Adherence in Adolescents with Psychiatric Disorders

Both

Mechler

Niemeyer

et al. 2021

Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapi

Self Cite

View full text Add to dashboard Cite

Abstract. Objective: This study investigates whether adolescents’ adherence to psychotropic medication is associated with demographic and socioeconomic factors, and to what extent parents’ assessments of their offspring’s attitudes toward treatment correspond with the adolescents’ self-report. Methods: This study is part of the multicenter SEMA study (Subjective Experience and Medication Adherence in Adolescents with Psychiatric Disorders). Adolescents’ subjective attitudes toward medication and their adherence were assessed using the patient and parent versions of the QATT (Questionnaire on Attitudes Toward Treatment) and the MARS (Medication Adherence Rating Scale). Furthermore, we collected socioeconomic and demographic data. Results: Of the n = 75 adolescents included in the study, n = 45 (60 %) were classified as completely adherent. Patients receiving monotherapy were more often completely adherent than those receiving a combination of different medications. There was no statistically significant association between adherence and demographic or socioeconomic factors. Consensus between adolescents and their parents regarding adolescents’ attitudes toward treatment ranged from slight (κ = 0.157) to fair (κ = 0.205). Conclusion: Incomplete medication adherence in adolescents with psychiatric disorders is a common phenomenon and still poorly understood. Demographic and socioeconomic factors do not seem to be relevant in this respect. However, adolescents’ subjective attitudes towards medication, which parents are presumably unable to adequately assess, warrant more careful consideration in future research.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Medication Adherence in Adolescents with Psychiatric Disorders

Both

Mechler

Niemeyer

et al. 2021

Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapi

Self Cite

View full text Add to dashboard Cite

show abstract

“…Weitere jüngere Initiativen -i. d. R. ohne Finanzierung durch Drittmittel -konzentrierten sich z. B. auf (Netzwerk)-Meta-Analysen zur Medikamentenwirksamkeit (Cortese et al, 2017;Kanters et al, 2016), unzureichende Medikamenten-Adhärenz (Häge et al, 2018;Niemeyer et al, 2018), Netzwerkstrukturen (Persico et al, 2015) sowie ethische Fragestellungen bei klinischer Anwendung und Forschung zu Psychopharmaka in der KJP (Dittmann, 2018;Gerlach & Warnke, 2016;Rothenberger & Rothenberger, 2012).…”

Section: Neuere Entwicklungenunclassified

Psychopharmakologieforschung in der Kinder- und Jugend- psychiatrie – Entwicklungen, Herausforderungen, Perspektiven

Dittmann

Rothenberger

2019

Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapi

Self Cite

View full text Add to dashboard Cite

“…Since 2012, an ongoing non-funded research program (SEMA, [22,38] of the RG has focussed on the inadequately investigated topic of, medication (non-)adherence; this work was awarded the AGNP (German equivalent to ECNP/CINP) prize 2018 for psychopharmacology [39].…”

Section: -2018: Back To University Cap and Academiamentioning

confidence: 99%

Child & Adolescent Psychiatry in Development - A Personal Retrospective Account Across Five Decades

Dittmann¹

2019

Int J Psychiatr Res

Self Cite

View full text Add to dashboard Cite

This personal account covers first steps and the individual development of the author within the-then in Germany newly established-field of ,child and adolescent psychiatry (CAP)', across a five-decade period, both in national and international environments, in clinical, academic, and pharmaceutical industry settings. Early years in medical school, practical experience, and psychology studies, succeeded by theses and examinations, were all directed to successfully gain adequate knowledge/skills to become a well-trained CAP clinician. Specialist residencies followed, in CAP/psychosomatics, paediatrics and adult psychiatry. In parallel to broad clinical responsibilities, soon, first research activities, successful grant applications, and intensive collaborations with publicly funded research consortia were strongly stimulated, to start an academic career. Clinical research in CAP areas of, e.g., psychoendocrinology/intersexuality, psychophysiology, psychopharmacology, migrant psychiatry, coping and compliance in somatic disease were pursued, including a 2-year research assignment abroad (USA). Unexpectedly, back in Germany, the author joined clinical CNS research in an international pharmaceutical company for several years, finally focussing on studies in juveniles. Over the last decade of his professional life, he became endowed chair, professor and director of a research group for ‚paediatric psychopharmacology' in a university department, the first of its kind in Europe. Currently open questions and challenges in this field conclude the report.

show abstract

“When I Stop My Medication, Everything Goes Wrong”: Content Analysis of Interviews with Adolescent Patients Treated with Psychotropic Medication

Cited by 11 publications

References 22 publications

Medication Adherence in Adolescents with Psychiatric Disorders

Medication Adherence in Adolescents with Psychiatric Disorders

Psychopharmakologieforschung in der Kinder- und Jugend- psychiatrie – Entwicklungen, Herausforderungen, Perspektiven

Child & Adolescent Psychiatry in Development - A Personal Retrospective Account Across Five Decades

Contact Info

Product

Resources

About